How to Build and Sell a Biotech in 2024
Listen now
Description
With a combined deal value of $29bn under their belts this year, four CEOs reflect on what they’ve learned from their successes – and failures. Roberto Bellini (who sold BELLUS Health), Mark McKenna (Prometheus), Bill Meury (Karuna Therapeutics) and Dan O’Connor (Ambrx Biopharma) also consider the current market for biopharma M&A and what buyers are seeking today.
More Episodes
With over $1 trillion in transactions under his belt, Larry Grafstein, Deputy Chairman, Global Investment Banking, RBC Capital Markets, shares career insights and deal strategies. This episode was originally recorded with The Investment Banking Leaders Podcast on September 23, 2024.
Published 10/16/24
Published 10/16/24
As U.S. issuances surge and redemptions from the low-rate era come due, the debt markets are in a dynamic phase, but what can issuers and investors expect next? Vito Sperduto is joined by Robert McCormack, Global Head of Debt Capital Markets, and Allison MacKinnon, Head of UK & European...
Published 10/09/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
